Namal Nawana is expected to take the reins in May, and he has a knack for business turnarounds.
News & Features
GE Healthcare is set to sell its Value-Based Care division to Veritas Capital for about $1.05 billion.
A medtech analyst shares takeaways from a recent discussion with a Mount Sinai Health System supply chain executive about Amazon entering the hospital supplies market.
The more characteristics a product has that are associated with successful risk-sharing arrangements, the more such an arrangement is likely to succeed.
W.L. Gore & Associates' Cardioform can now effectively compete against Abbott's Amplatzer technology, which also has an indication to reduce the risk of recurrent ischemic stroke through PFO closure.
Intersect ENT brings its fourth commercial product, the Sinuva Sinus implant, to market to treat nasal polyp disease.
Medical challenges that are tough to solve or underserved could be addressed through open innovation, says one BIOMEDevice Boston speaker.
Risk-sharing arrangements are becoming part of the norm in the medical device field, but when are they most beneficial?
Avinger is assembling a slew of indications and clearances to help expand the prowess of its Pantheris lumivascular artherectomy system in treating patients suffering from peripheral arterial disease (PAD).
Embedded microsensors continuously monitor foot temperature to detect and prevent diabetic foot ulcers.